Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Abdellatif TaziGwenaël LorillonJulien HarocheAntoine NeelStéphane DominiqueAchille AoubaJean-David BouazizConstance de Margerie-MelonEmmanuelle BugnetVincent CottinThibault ComontChristian LavigneJean-Emmanuel KahnJean DonadieuSylvie ChevretPublished in: Orphanet journal of rare diseases (2017)
Vinblastine is an effective and well-tolerated first-line treatment for adult LCH except in patients with lung involvement and impaired lung function. However, a significant portion of patients experienced LCH reactivation during long-term follow up. As in childhood LCH, the presence of risk organ involvement has a negative impact on patient prognosis.
Keyphrases